Beijing Quantum Hi Tech

Quantum Hi-Tech, including its Beijing-based pharmaceutical division, is a global leader in the research, development, and production of prebiotics and micro-ecological health solutions. The company specializes in high-purity Fructo-oligosaccharides (FOS) and Galacto-oligosaccharides (GOS), which serve as functional ingredients to enhance gut microbiome health. Formerly a core business of the Shenzhen-listed ChemPartner Pharmatech, the prebiotic operations were acquired by the British multinational Tate & Lyle in 2022 for approximately 237 million dollars. Quantum Hi-Tech operates advanced manufacturing facilities and R&D centers focused on the clinical benefits of fibers in infant nutrition, dairy, and dietary supplements. Its pharmaceutical arm in Beijing specifically targets the development of micro-ecological preparations for therapeutic use in gastrointestinal and metabolic health. The company's platform integrates enzymatic engineering with microbiome science to provide evidence-based nutritional and pharmaceutical solutions.